NYX-2925, A NOVEL, NON-OPIOID, SMALL-MOLECULE MODULATOR OF THE N-METHYL-d-ASPARTATE RECEPTOR (NMDAR), DEMONSTRATES POTENTIAL TO TREAT CHRONIC, SUPRASPINAL CENTRALIZED PAIN CONDITIONS
Article in Medicine in Drug Discovery (March 2021)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Medicine in Drug Discovery (March 2021)
Article in Eye & Contact Lens Science & Clinical Practice (May 2020)
Article in Pharmaceuticals (June 2019)